The patent situation regarding medical devices in the EU may not be as volatile as that of their pharmaceutical counterparts, but litigation in the sector appears to be on the increase. Whilst the European Commission’s focus on competition in the pharmaceutical sector may begin to fade, there are suggestions that it may turn its gaze towards medical devices...
Scrip Regulatory Affairs
Patents and the EU medical devices sector: a slumbering volcano
31 December 2009
Faraz Kermani
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- European Commission outlines new patent court to rescue single patent talks
- European Commission outlines new patent court to rescue single patent talks
- Value based pricing will not fit with reference pricing, says UK's ABPI
- Companies warned against withholding information from regulators in different regions
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
